Northstar Distribution Center 8912 Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Northstar Distribution Center 8912 Pharmaceutical Import Records from India — 35 Products, $80.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Northstar Distribution Center 8912 — Pharmaceutical Importer Profile (2026) | 35 Products, $80.5M Trade | TransData Nexus

Northstar Distribution Center 8912

Pharmaceutical Importer · United States · Cardiovascular Focus · $80.5M Total Trade · DGFT Verified

Northstar Distribution Center 8912 is a pharmaceutical importer based in United States with a total trade value of $80.5M across 35 products in 17 therapeutic categories. Based on 2,215 verified import shipments from Indian Customs (DGFT) records, Northstar Distribution Center 8912 is the #1 buyer in 2 products including Clopidogrel, Digoxin. Northstar Distribution Center 8912 sources from 26 verified Indian suppliers, with Aurobindo Pharma Ltd accounting for 19.8% of imports.

Northstar Distribution Center 8912 — Import Portfolio & Supplier Network

Northstar Distribution Center 8912 import network — 35 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Northstar Distribution Center 8912?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Ltd	$24.3M	1,048	19.8%
Zydus Lifesciences Limited	$15.9M	531	13.0%
Dr.reddy's Laboratories Ltd

What Formulations Does Northstar Distribution Center 8912 Import?

Formulation	Value	Ships
Levetiracetam oral solution USP 100MG/ML	$1.4M	28
Pharmaceutical medicine for human use	$1.0M	25
Esomeprazole magnesium dr capsules USP	$808.8K	26
Ondansetron hcl tablets 4MG	$722.6K	20
Amoxicillin and clavulanate potassium	$700.2K	29
Pharmaceutical medicine for human use	$696.0K	20
Levetiracetam oral solution USP 100MG/ML, 473ML	$674.7K	16
Pharmaceuticals- rosuvastatin TAB 10MG	$554.3K	13
Drug&pha.harmles med-triamcinolone	$548.2K	27
Pharmaceutical medicine for human use	$492.7K	13
Pharmaceuticals- rosuvastatin TAB 20MG	$485.2K	13
Lamotrigine extended release tablets	$468.2K	13
Celecoxib capsule 200MG ndc	$450.0K	9
Pharmaceutical medicine for human use -mesalamine delayed release tablets 1.2 GM- 1 x 120 - econo 1 x	$450.0K	9
Drugs and pharmaceuticals harmless medicines emtricitabine 200MG + tenofovir disoproxil fumarate 300MG	$445.3K	15

Northstar Distribution Center 8912 imports 2,779 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 30 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rosuvastatin	Cardiovascular	$6.9M	150	1.5%	14
2	Omeprazole	Gastrointestinal	$6.8M	179	1.1%	15
3	Clopidogrel	Cardiovascular	$6.5M	130	2.6%	1
4	Metoprolol	Cardiovascular	$6.3M	191	0.8%	10
5	Amoxicillin	Antibiotics	$5.8M	120	1.0%	13
6	Ondansetron	Gastrointestinal	$5.1M	156	4.2%	5
7	Iron	Vitamins & Supplements	$4.2M	84	0.9%	13
8	Spironolactone	Diuretics	$4.2M	84	2.1%	5
9	Celecoxib	Analgesics & Antipyretics	$3.5M	135	2.6%	6
10	Mesalamine	Gastrointestinal	$3.1M	63	0.2%	3
11	Clindamycin	Antibiotics	$2.9M	72	3.3%	10
12	Fluconazole	Antifungals	$2.7M	125	2.9%	4
13	Cetirizine	Antihistamines & Allergy	$2.1M	67	1.2%	17
14	Cefpodoxime	Advanced Antibiotics	$2.0M	60	2.5%	8
15	Pioglitazone	Diabetes & Endocrine	$1.8M	171	4.8%	6
16	Pravastatin	Cardiovascular	$1.7M	39	3.7%	6
17	Emtricitabine	Antiviral & HIV Medications	$1.7M	43	1.4%	12
18	Chloroquine	Antimalarial & Antiparasitic	$1.6M	33	1.0%	3
19	Hydroxychloroquine	Antimalarial & Antiparasitic	$1.6M	33	1.2%	2
20	Terbinafine	Antifungals	$1.4M	28	5.1%	3
21	Cefuroxime	Advanced Antibiotics	$1.1M	45	0.9%	17
22	Vati	Ayurvedic & Herbal Products	$1.1M	24	4.0%	5
23	Sunitinib	Advanced Oncology	$900.0K	18	1.4%	3
24	Paclitaxel	Oncology	$850.0K	17	1.0%	12
25	Bisoprolol	Cardiovascular	$844.4K	46	1.0%	13
26	Doxycycline	Antibiotics	$700.0K	14	0.6%	9
27	Digoxin	Cardiovascular	$597.5K	20	27.4%	1
28	Budesonide	Respiratory	$550.0K	11	0.3%	12
29	Febuxostat	Lipid & Metabolism	$537.0K	11	1.1%	14
30	Aspirin	Analgesics & Antipyretics	$512.7K	22	1.4%	14

Northstar Distribution Center 8912 imports 35 pharmaceutical products across 17 categories into United States totaling $80.5M. The company is the #1 buyer for 2 products: Clopidogrel, Digoxin.

Northstar Distribution Center 8912 — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Northstar Distribution Center 8912 is a prominent pharmaceutical importer and distributor based in Memphis, Tennessee, United States. Operating as a key player in the U.S. pharmaceutical supply chain, the company specializes in sourcing and distributing a wide array of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. With a substantial import value of $80.5 million USD over the period from 2022 to 2026, Northstar Distribution Center 8912 has established itself as a significant entity in the pharmaceutical distribution sector. The company imports a diverse portfolio of 35 products across 17 therapeutic categories, underscoring its extensive reach and influence in the market.

The company's operations are characterized by a high level of supplier diversification, with verified Indian suppliers accounting for a significant portion of its imports. Notably, Aurobindo Pharma Ltd. leads with $24.3 million USD in imports, followed by Zydus Lifesciences Limited and Dr. Reddy's Laboratories Ltd., each contributing approximately $15.9 million USD. This extensive supplier network reflects Northstar Distribution Center 8912's strategic approach to sourcing, ensuring a steady and reliable supply of pharmaceutical products to meet the demands of the U.S. market.

2Distribution Network

Northstar Distribution Center 8912 operates a robust distribution network centered in Memphis, Tennessee, strategically located to facilitate efficient logistics and timely delivery of pharmaceutical products across the United States. The facility at 4853 Crumpler Road serves as the primary hub for its operations, enabling effective management of inventory and distribution processes. While specific details regarding additional warehouse locations and logistics capabilities are not publicly disclosed, the centralization of operations in Memphis suggests a streamlined approach to supply chain management, leveraging the city's strategic position and infrastructure to optimize distribution efficiency.

3Industry Role

In the U.S. pharmaceutical supply chain, Northstar Distribution Center 8912 functions primarily as a wholesaler and distributor. By importing a diverse range of finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in bridging the gap between global manufacturers and domestic healthcare providers. This intermediary position enables Northstar Distribution Center 8912 to ensure the availability of essential medications across various therapeutic categories, thereby contributing to the overall accessibility and affordability of pharmaceuticals in the U.S. market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Northstar Distribution Center 8912

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Northstar Distribution Center 8912's sourcing strategy exhibits a notable concentration on Indian pharmaceutical suppliers, with the top five suppliers accounting for approximately 60% of its total imports. This concentration indicates a strategic choice to leverage India's robust pharmaceutical manufacturing capabilities, which are recognized for producing high-quality generics at competitive prices. The substantial import values from suppliers such as Aurobindo Pharma Ltd., Zydus Lifesciences Limited, and Dr. Reddy's Laboratories Ltd. suggest stable and long-term relationships, likely characterized by favorable terms and consistent product quality.

However, this sourcing concentration also presents potential risks. Any disruptions in the Indian pharmaceutical sector—such as regulatory changes, manufacturing issues, or geopolitical tensions—could impact the supply chain's stability. To mitigate these risks, Northstar Distribution Center 8912 may consider diversifying its supplier base further and establishing contingency plans to ensure a continuous and reliable supply of pharmaceutical products to the U.S. market.

2Supply Chain Resilience

The resilience of Northstar Distribution Center 8912's supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's extensive supplier network, comprising 26 unique suppliers, indicates a level of diversification that can help buffer against potential disruptions. Additionally, the importation of 2,779 unique pharmaceutical formulations suggests a broad product portfolio, which can provide flexibility in meeting market demands and adapting to supply chain challenges.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal requirements for drug safety, efficacy, and quality. Under this framework, all drugs imported into the U.S. must be approved by the FDA and comply with its regulations to ensure they are safe and effective for public use.

For Indian pharmaceutical exporters, understanding and adhering to the FDA's regulatory requirements is crucial. This includes ensuring that manufacturing facilities are registered with the FDA, that products are approved through the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) processes, and that labeling and packaging meet FDA standards. Compliance with these regulations facilitates smoother entry into the U.S. market and helps maintain the integrity of the pharmaceutical supply chain.

2Import Licensing & GMP

Import licensing for pharmaceutical products into the United States involves several key requirements. Importers must file an entry notice and an entry bond with U.S. Customs and Border Protection (CBP) to notify the FDA of the imported goods. The FDA then reviews the shipment to determine its admissibility based on compliance with the FD&C Act and related regulations. If a product is found to be in violation, it may be refused entry, and the importer is required to re-export or destroy the product under appropriate supervision.

Northstar Distribution Center 8912 — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Northstar Distribution Center 8912's product strategy focuses on importing a diverse range of pharmaceutical formulations across various therapeutic categories, with a particular emphasis on cardiovascular, gastrointestinal, and antibiotic medications. This strategic focus aligns with the significant demand for these therapeutic areas in the U.S. market, driven by the prevalence of chronic diseases such as hypertension, diabetes, and infections. By concentrating on these high-demand categories, Northstar Distribution Center 8912 ensures that it meets the critical needs of healthcare providers and patients, thereby strengthening its position in the pharmaceutical distribution sector.

The company's top five imported

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Northstar Distribution Center 8912

What products does Northstar Distribution Center 8912 import from India?

Northstar Distribution Center 8912 imports 35 pharmaceutical products across 17 categories. Top imports: Rosuvastatin ($6.9M), Omeprazole ($6.8M), Clopidogrel ($6.5M), Metoprolol ($6.3M), Amoxicillin ($5.8M).

Who supplies pharmaceuticals to Northstar Distribution Center 8912 from India?

Northstar Distribution Center 8912 sources from 26 verified Indian suppliers. The primary supplier is Aurobindo Pharma Ltd (19.8% of imports, $24.3M).

What is Northstar Distribution Center 8912's total pharmaceutical import value?

Northstar Distribution Center 8912's total pharmaceutical import value from India is $80.5M, based on 2,215 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Northstar Distribution Center 8912 focus on?

Northstar Distribution Center 8912 imports across 17 categories. The largest: Cardiovascular (28.5%), Gastrointestinal (18.7%), Antibiotics (11.7%).

Get Full Northstar Distribution Center 8912 Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Northstar Distribution Center 8912

Northstar Distribution Center 8912 — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Northstar Distribution Center 8912?

What Formulations Does Northstar Distribution Center 8912 Import?

What Products Does Northstar Distribution Center 8912 Import?

Top Products by Import Value

Northstar Distribution Center 8912 Therapeutic Categories — 17 Specializations